Sfoglia per Autore
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
2011 F. Girolami;S. Bardi;L. Berti;F. Cecchi;E. Servettini;B. Tomberli;F. Torricelli;I. Olivotto
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.
2013 Tomberli, B; Cecchi, F; Sciagrà, R; Berti, V; Lisi, F; Torricelli, F; Morrone, A; Castelli, G; Yacoub, Mh; Olivotto, I.
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy
2013 Olivotto I.; Maron B.J.; Tomberli B.; Appelbaum E.; Salton C.; Haas T.S.; Gibson C.M.; Nistri S.; Servettini E.; Chan R.H.; Udelson J.E.; Lesser J.R.; Cecchi F.; Manning W.J.; Maron M.S.
Confronting the archipelago of primary myocardial diseases: from the comprehension of genetic basis, molecular mechanisms and clinical correlates to the development of novel therapeutic approaches.
2014 BENEDETTA TOMBERLI
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
2014 Chan R.H.; Maron B.J.; Olivotto I.; Pencina M.J.; Assenza G.E.; Haas T.; Lesser J.R.; Gruner C.; Crean A.M.; Rakowski H.; Udelson J.E.; Rowin E.; Lombardi M.; Cecchi F.; Tomberli B.; Spirito P.; Formisano F.; Biagini E.; Rapezzi C.; De Cecco C.N.; Autore C.; Cook E.F.; Hong S.N.; Gibson C.M.; Manning W.J.; Appelbaum E.; Maron M.S.
Novel α-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study.
2014 F. Girolami;M. Iascone;B. Tomberli;S. Bardi;M. Benelli;G. Marseglia;C. Pescucci;L. Pezzoli;M. E. Sana;C. Basso;N. Marziliano;P. A. Merlini;A. Fornaro;F. Cecchi;F. Torricelli;I. Olivotto
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients with Hypertrophic Cardiomyopathy
2015 Chan R.H.; Maron B.J.; Olivotto I.; Assenza G.E.; Haas T.S.; Lesser J.R.; Gruner C.; Crean A.M.; Rakowski H.; Rowin E.; Udelson J.; Lombardi M.; Tomberli B.; Spirito P.; Formisano F.; Marra M.P.; Biagini E.; Autore C.; Manning W.J.; Appelbaum E.; Roberts W.C.; Basso C.; Maron M.S.
Defining phenotypes and disease progression in sarcomeric cardiomyopathies: Contemporary role of clinical investigations
2015 Olivotto I.; D'Amati G.; Basso C.; Van Rossum A.; Patten M.; Emdin M.; Pinto Y.; Tomberli B.; Camici P.G.; Michels M.
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy
2016 Maron M.S.; Rowin E.J.; Olivotto I.; Casey S.A.; Arretini A.; Tomberli B.; Garberich R.F.; Link M.S.; Chan R.H.M.; Lesser J.R.; Maron B.J.
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy
2017 Tomberli, Benedetta; Cappelli, Francesco; Perfetto, Federico; Olivotto, Iacopo
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy
2017 Weissler-Snir A.; Hindieh W.; Gruner C.; Fourey D.; Appelbaum E.; Rowin E.; Care M.; Lesser J.R.; Haas T.S.; Udelson J.E.; Manning W.J.; Olivotto I.; Tomberli B.; Maron B.J.; Maron M.S.; Crean A.M.; Rakowski H.; Chan R.H.
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience
2017 Fornaro, Alessandra; Olivotto, Iacopo; Rigacci, Luigi; Ciaccheri, Mauro; Tomberli, Benedetta; Ferrantini, Cecilia; Coppini, Raffaele; Girolami, Francesca; Mazzarotto, Francesco; Chiostri, Marco; Milli, Massimo; Marchionni, Niccolò; Castelli, Gabriele
Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications
2018 Girolami F.; Frisso G.; Benelli M.; Crotti L.; Iascone M.; Mango R.; Mazzaccara C.; Pilichou K.; Arbustini E.; Tomberli B.; Limongelli G.; Basso C.; Olivotto I.
A Brief History of Coronary Artery Stents
2018 Tomberli, Benedetta; Mattesini, Alessio; Baldereschi, Giorgio Iacopo; Di Mario, Carlo*
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy
2018 Cavigli L.; Fumagalli C.; Maurizi N.; Rossi A.; Arretini A.; Targetti M.; Passantino S.; Girolami F.; Tomberli B.; Baldini K.; Tomberli A.; Antoniucci D.; Yacoub M.H.; Marchionni N.; Stefano P.L.; Cecchi F.; Olivotto I.
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study
2018 Olivotto, Iacopo; Camici, Paolo G; Merlini, Piera Angelica; Rapezzi, Claudio; Patten, Monica; Climent, Vicent; Sinagra, Gianfranco; Tomberli, Benedetta; Marin, Francisco; Ehlermann, Philipp; Maier, Lars S; Fornaro, Alessandra; Jacobshagen, Claudius; Ganau, Antonello; Moretti, Luciano; Hernandez Madrid, Antonio; Coppini, Raffaele; Reggiardo, Giorgio; Poggesi, Corrado; Fattirolli, Francesco; Belardinelli, Luiz; Gensini, Gianfranco; Mugelli, Alessandro
Terapia anticoagulante e antiaggregante
2019 Fumagalli, Stefano; Tomberli, Benedetta
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy
2019 Maurizi N.; Michels M.; Rowin E.J.; Semsarian C.; Girolami F.; Tomberli B.; Cecchi F.; Maron M.S.; Olivotto I.; Maron B.J.
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials
2019 Dicembrini I.; Tomberli B.; Nreu B.; Baldereschi G.I.; Fanelli F.; Mannucci E.; Monami M.
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome
2020 De Gregorio, Maria Grazia; Girolami, Francesca; Tomberli, Benedetta; Rossi, Guendalina; Tomberli, Alessia; Baldini, Katia; Olivotto, Iacopo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy]. | 2011 | F. Girolami;S. Bardi;L. Berti;F. Cecchi;E. Servettini;B. Tomberli;F. Torricelli;I. Olivotto | |
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. | 2013 | Tomberli, B; Cecchi, F; Sciagrà, R; Berti, V; Lisi, F; Torricelli, F; Morrone, A; Castelli, G; Yacoub, Mh; Olivotto, I. | |
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy | 2013 | Olivotto I.; Maron B.J.; Tomberli B.; Appelbaum E.; Salton C.; Haas T.S.; Gibson C.M.; Nistri S.; Servettini E.; Chan R.H.; Udelson J.E.; Lesser J.R.; Cecchi F.; Manning W.J.; Maron M.S. | |
Confronting the archipelago of primary myocardial diseases: from the comprehension of genetic basis, molecular mechanisms and clinical correlates to the development of novel therapeutic approaches. | 2014 | BENEDETTA TOMBERLI | |
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy | 2014 | Chan R.H.; Maron B.J.; Olivotto I.; Pencina M.J.; Assenza G.E.; Haas T.; Lesser J.R.; Gruner C.; Crean A.M.; Rakowski H.; Udelson J.E.; Rowin E.; Lombardi M.; Cecchi F.; Tomberli B.; Spirito P.; Formisano F.; Biagini E.; Rapezzi C.; De Cecco C.N.; Autore C.; Cook E.F.; Hong S.N.; Gibson C.M.; Manning W.J.; Appelbaum E.; Maron M.S. | |
Novel α-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study. | 2014 | F. Girolami;M. Iascone;B. Tomberli;S. Bardi;M. Benelli;G. Marseglia;C. Pescucci;L. Pezzoli;M. E. Sana;C. Basso;N. Marziliano;P. A. Merlini;A. Fornaro;F. Cecchi;F. Torricelli;I. Olivotto | |
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients with Hypertrophic Cardiomyopathy | 2015 | Chan R.H.; Maron B.J.; Olivotto I.; Assenza G.E.; Haas T.S.; Lesser J.R.; Gruner C.; Crean A.M.; Rakowski H.; Rowin E.; Udelson J.; Lombardi M.; Tomberli B.; Spirito P.; Formisano F.; Marra M.P.; Biagini E.; Autore C.; Manning W.J.; Appelbaum E.; Roberts W.C.; Basso C.; Maron M.S. | |
Defining phenotypes and disease progression in sarcomeric cardiomyopathies: Contemporary role of clinical investigations | 2015 | Olivotto I.; D'Amati G.; Basso C.; Van Rossum A.; Patten M.; Emdin M.; Pinto Y.; Tomberli B.; Camici P.G.; Michels M. | |
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy | 2016 | Maron M.S.; Rowin E.J.; Olivotto I.; Casey S.A.; Arretini A.; Tomberli B.; Garberich R.F.; Link M.S.; Chan R.H.M.; Lesser J.R.; Maron B.J. | |
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy | 2017 | Tomberli, Benedetta; Cappelli, Francesco; Perfetto, Federico; Olivotto, Iacopo | |
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy | 2017 | Weissler-Snir A.; Hindieh W.; Gruner C.; Fourey D.; Appelbaum E.; Rowin E.; Care M.; Lesser J.R.; Haas T.S.; Udelson J.E.; Manning W.J.; Olivotto I.; Tomberli B.; Maron B.J.; Maron M.S.; Crean A.M.; Rakowski H.; Chan R.H. | |
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience | 2017 | Fornaro, Alessandra; Olivotto, Iacopo; Rigacci, Luigi; Ciaccheri, Mauro; Tomberli, Benedetta; Ferrantini, Cecilia; Coppini, Raffaele; Girolami, Francesca; Mazzarotto, Francesco; Chiostri, Marco; Milli, Massimo; Marchionni, Niccolò; Castelli, Gabriele | |
Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications | 2018 | Girolami F.; Frisso G.; Benelli M.; Crotti L.; Iascone M.; Mango R.; Mazzaccara C.; Pilichou K.; Arbustini E.; Tomberli B.; Limongelli G.; Basso C.; Olivotto I. | |
A Brief History of Coronary Artery Stents | 2018 | Tomberli, Benedetta; Mattesini, Alessio; Baldereschi, Giorgio Iacopo; Di Mario, Carlo* | |
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy | 2018 | Cavigli L.; Fumagalli C.; Maurizi N.; Rossi A.; Arretini A.; Targetti M.; Passantino S.; Girolami F.; Tomberli B.; Baldini K.; Tomberli A.; Antoniucci D.; Yacoub M.H.; Marchionni N.; Stefano P.L.; Cecchi F.; Olivotto I. | |
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study | 2018 | Olivotto, Iacopo; Camici, Paolo G; Merlini, Piera Angelica; Rapezzi, Claudio; Patten, Monica; Climent, Vicent; Sinagra, Gianfranco; Tomberli, Benedetta; Marin, Francisco; Ehlermann, Philipp; Maier, Lars S; Fornaro, Alessandra; Jacobshagen, Claudius; Ganau, Antonello; Moretti, Luciano; Hernandez Madrid, Antonio; Coppini, Raffaele; Reggiardo, Giorgio; Poggesi, Corrado; Fattirolli, Francesco; Belardinelli, Luiz; Gensini, Gianfranco; Mugelli, Alessandro | |
Terapia anticoagulante e antiaggregante | 2019 | Fumagalli, Stefano; Tomberli, Benedetta | |
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy | 2019 | Maurizi N.; Michels M.; Rowin E.J.; Semsarian C.; Girolami F.; Tomberli B.; Cecchi F.; Maron M.S.; Olivotto I.; Maron B.J. | |
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials | 2019 | Dicembrini I.; Tomberli B.; Nreu B.; Baldereschi G.I.; Fanelli F.; Mannucci E.; Monami M. | |
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome | 2020 | De Gregorio, Maria Grazia; Girolami, Francesca; Tomberli, Benedetta; Rossi, Guendalina; Tomberli, Alessia; Baldini, Katia; Olivotto, Iacopo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile